Robert B. Couch | Academic Influence

Q: What Schools Are Affiliated With Robert B. Couch

Robert B. Couch is affiliated with the following schools: University of Texas Medical Branch, Western Oregon University, Earlham College, Baylor College of Medicine, Baylor University, University of Rochester, Willamette University

Why Is Robert B. Couch Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert B. Couch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Impact of respiratory virus infections on persons with chronic underlying conditions. (2000) (562)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus (2012) (496)
Immunity to influenza in man. (1983) (463)
Interpandemic influenza in the Houston area, 1974-76. (1978) (408)
Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. (1996) (350)
A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. (1970) (258)
Clinical responses to undiluted and diluted smallpox vaccine. (2002) (249)
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus (2016) (247)
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. (1997) (220)
Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease (2015) (210)
Induction of partial immunity to influenza by a neuraminidase-specific vaccine. (1974) (209)
Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. (2013) (195)
Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. (2011) (192)
Influenza A virus infections among hospitalized adult bone marrow transplant recipients. (1994) (189)
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. (2006) (183)
RIBAVIRIN SMALL-PARTICLE AEROSOL TREATMENT OF INFLUENZA (1981) (169)
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. (2007) (165)
Influenza: its control in persons and populations. (1986) (161)
Herpes Zoster‐Associated Encephalitis: Clinicopathologic Report of 12 Cases and Review of the Literature (1983) (157)
Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. (1966) (157)
Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. (1996) (157)
Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2 (2006) (156)
Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. (1988) (152)
Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. (1999) (149)
Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. (2004) (149)
Effects of tetracycline on leukotaxis. (1974) (144)
Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. (1991) (141)
Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. (1995) (140)
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. (2006) (139)
Prevention and treatment of influenza. (2000) (139)
Integrative genomic analysis of the human immune response to influenza vaccination (2013) (122)
Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses (1979) (122)
Effects of Low- and High-Passage Influenza Virus Infection in Normal and Nude Mice (1977) (122)
Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978. (1983) (120)
Influenza among hospitalized adults with leukemia. (1997) (119)
A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine (2012) (118)
The role of nasal secretion and serum antibody in the rhinovirus common cold. (1966) (116)
Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. (1971) (116)
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. (2006) (115)
Live attenuated and inactivated influenza vaccine in school-age children. (1990) (113)
Seasonal inactivated influenza virus vaccines. (2008) (110)
IMMUNIZATION WITH TYPES 4 AND 7 ADENOVIRUS BY SELECTIVE INFECTION OF THE INTESTINAL TRACT. (1963) (106)
The Desire to Acquire and IPO Long-Run Underperformance (2010) (105)
Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice (1980) (105)
Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread (2013) (99)
Host Transcriptional Response to Influenza and Other Acute Respiratory Viral Infections – A Prospective Cohort Study (2015) (99)
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. (2010) (99)
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. (1980) (96)
Sporadic occurrence of zoonotic swine influenza virus infections (1984) (96)
Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. (1991) (94)
Assessment of experimental and natural viral aerosols. (1966) (94)
Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children (1993) (93)
Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus (2012) (89)
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans. (1995) (88)
The common cold: control? (1984) (88)
Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. (1980) (88)
False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid Enzyme-Linked Immunosorbent Assay Due to HCoV-OC43 and HCoV-229E Rectified by Western Blotting with Recombinant SARS-CoV Spike Polypeptide (2004) (85)
Infection with influenza A/Victoria virus in Houston families, 1976 (1981) (85)
INFECTION WITH ARTIFICIALLY PROPAGATED EATON AGENT (MYCOPLASMA PNEUMONIAE). IMPLICATIONS FOR DEVELOPMENT OF ATTENUATED VACCINE FOR COLD AGGLUTININ-POSITIVE PNEUMONIA. (1964) (84)
Airborne transmission of respiratory infection with coxsackievirus A type 21. (1970) (84)
Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren. (1996) (82)
Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum. (1967) (80)
Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease (2015) (77)
The leukocyte response during viral respiratory illness in man. (1966) (77)
An overview of serum antibody responses to influenza virus antigens. (2003) (76)
Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. (1970) (76)
Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12 1 This paper was presented at the First International Conference on Immunology and Aging, June 13–19, 1996, Bethesda, MD, USA. 1 (1997) (76)
Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84 (1985) (75)
STUDIES WITH RHINOVIRUSES IN VOLUNTEERS: PRODUCTION OF ILLNESS, EFFECT OF NATURALLLY ACQUIRED ANTIBODY, AND DEMONSTRATION OF A PROTECTIVE EFFECT NOT ASSOCIATED WITH SERUM ANTIBODY. (1964) (74)
Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant. (1993) (72)
Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. (1976) (70)
Significance of Herpesvirus hominis in respiratory secretions of man. (1968) (70)
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol (1984) (69)
Epidemiology of Influenza A virus infection in patients with acute or chronic leukemia (1995) (68)
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults (1994) (67)
Improvement of inactivated influenza virus vaccines. (1997) (66)
Clinical and epidemiological importance of influenza a viruses resistant to amantadine and rimantadine (1992) (66)
The effects of influenza on host defenses. (1981) (65)
Exposure to Cold Environment and Rhinovirus Common Cold (1968) (65)
Quantitative rhinovirus shedding patterns in volunteers. (1966) (65)
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. (2007) (65)
Advances in Influenza Virus Vaccine Research a (1993) (63)
Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy (1993) (62)
Effectiveness of rimantadine prophylaxis of children within families. (1986) (61)
Reinfection with influenza A (H3N2) virus in young children and their families. (1979) (60)
Antibody to Mycoplasma pneumoniae in Nasal Secretions and Sputa of Experimentally Infected Human Volunteers (1973) (60)
Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes (1990) (59)
Maintenance of viability and comparison of identification methods for influenza and other respiratory viruses of humans (1977) (59)
PRODUCTION OF TRACHEOBRONCHITIS IN VOLUNTEERS WITH RHINOVIRUS IN A SMALL-PARTICLE AEROSOL. (1965) (59)
The influenza herald wave. (1982) (57)
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines. (2012) (57)
Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers. (1983) (55)
Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons. (1993) (55)
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly (1996) (55)
Estimating deaths due to influenza and respiratory syncytial virus. (2003) (54)
Homologous and heterologous resistance to rhinovirus common cold. (1965) (53)
PRODUCTION OF ILLNESS WITH A SMALL-PARTICLE AEROSOL OF COXSACKIE A21. (1965) (52)
Protein Composition of Nasal Secretion During Respiratory Virus Infection (1965) (52)
Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans (2012) (52)
Amantadine therapy of epidemic influenza A2-Hong Kong. (1970) (51)
Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant. (2007) (51)
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma. (2006) (51)
Editorial Response: Influenza, Influenza Virus Vaccine, and Human Immunodeficiency Virus Infection (1999) (51)
Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells. (1994) (50)
Current Research on Influenza and other Respiratory Viruses: II International Symposium (2000) (50)
Effects of infection with influenza virus on the function of polymorphonuclear leukocytes. (1981) (49)
Clinical trials of bivalent influenza A/New Jersey/76-A/Victoria/75 vaccines in the elderly. (1977) (47)
Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes. (1977) (46)
Interferon and Resistance to Upper Respiratory Virus Illness∗ (1969) (46)
Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose. (1984) (45)
The immunizing effect of influenza A/New Jersey/76 (Hsw1N1) virus vaccine administered intradermally and intramuscularly to adults. (1977) (44)
Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection (1978) (43)
Aerosol-induced adenoviral illness resembling the naturally occurring illness in military recruits. (1966) (41)
Pause on avian flu transmission research. (2012) (41)
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans. (2009) (41)
Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus. (1982) (40)
Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults. (1993) (40)
The Virtue of Participatory Governance: A MacIntyrean Alternative to Shareholder Maximization (2015) (39)
Clinical trials of monovalent influenza A/New Jersey/76 virus vaccines in adults: reactogenicity, antibody response, and antibody persistence. (1977) (38)
Antiviral Activity of Intranasally Applied Human Leukocyte Interferon (1978) (37)
Transmission Studies Resume for Avian Flu (2013) (37)
Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge. (1990) (37)
The minimal infectious dose of adenovirus type 4; the case for natural transmission by viral aerosol. (1969) (36)
The sedimentation behavior of rhinovirus neutralizing activity in nasal secretion and serum following the rhinovirus common cold. (1966) (36)
Experimental infection in man and horses with influenza A viruses. (1969) (36)
Atraumatic nasal biopsy for studies of respiratory virus infection in volunteers. (1968) (35)
Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold‐recombinant or inactivated influenza A virus vaccine (1996) (35)
Antiviral agents in influenza--summary of Influenza Workshop VIII. (1976) (35)
Dose-dependent neutralizing-antibody responses to vaccinia. (2004) (34)
Diagnosis of herpes simplex virus infection by immunofluorescence (1976) (34)
Superior antigen-specific CD4+T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older (2014) (33)
Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytes (2007) (33)
Prior Infections With Seasonal Influenza A/H1N1 Virus Reduced the Illness Severity and Epidemic Intensity of Pandemic H1N1 Influenza in Healthy Adults (2011) (33)
The lymphocyte response to influenza in humans. (1979) (33)
Pause on Avian Flu Transmission Research (2012) (32)
Efficacy of purified influenza subunit vaccines and relation to the major antigenic determinants on the hemagglutinin molecule. (1979) (32)
ROLE OF MYCOPLASMA (PPLO) IN HUMAN RESPIRATORY DISEASE. (1963) (31)
Chemotaxis of human leukocytes: responsiveness to Mycoplasma pneumoniae. (1973) (31)
Temperature-Sensitive Mutants of Influenza A Virus: Evaluation of A/Victoria/3/75-ts-1[E] Recombinant Viruses in Volunteers (1978) (31)
Influenza, influenza virus vaccine, and human immunodeficiency virus infection. (1999) (30)
Human interleukin-12 enhances interferon-gamma-producing influenza-specific memory CD8+ cytotoxic T lymphocytes. (1999) (30)
Global Gene Expression Profiling in Infants With Acute Respiratory Syncytial Virus Broncholitis Demonstrates Systemic Activation of Interferon Signaling Networks (2013) (30)
Rimantadine prophylaxis in children: a follow-up study. (1988) (30)
Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza. (1981) (30)
Lymohocyte-mediated cytotoxicity against influenza virus-infected cells: an in vitro method. (1975) (30)
Genetic approaches to attenuation of influenza A viruses for man. (1980) (29)
Effects of rhinovirus infection of pulmonary function of healthy human volunteers. (1976) (29)
Human influenza: aspects of the immune response to vaccination. (1969) (28)
BOLIVIAN HEMORRHAGIC FEVER PROBABLY TRANSMITTED BY PERSONAL CONTACT (1965) (28)
Current research on respiratory viral infections: Third International Symposium (2001) (28)
Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004. (2005) (27)
Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults. (1990) (27)
Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. (2001) (26)
Interest Tax Shields: A Barrier Options Approach (2012) (26)
Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission (1966) (24)
Effect of Human Nasal Secretions on the Antiviral Activity of Human Fibroblast and Leukocyte Interferon 1 (1976) (23)
Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge (1982) (22)
Antigenic analysis of H1N1 viruses isolated in the Houston metropolitan area during four successive seasons (1983) (21)
An outbreak of an influenza type A variant in a closed population: The effect of homologous and heterologous antibody on infection and illness. (1974) (21)
Human nasal epithelial cell culture system: evaluation of response to human interferons (1977) (21)
Elevated Human Dipeptidyl Peptidase 4 Expression Reduces the Susceptibility of hDPP4 Transgenic Mice to Middle East Respiratory Syndrome Coronavirus Infection and Disease (2018) (21)
Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein. (1994) (21)
First International Symposium on Influenza and Other Respiratory Viruses: summary and overview (1999) (21)
Herpes simplex encephalitis treated with vidarabine (adenine arabinoside). (1977) (21)
Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation. (1979) (20)
Induction of Immunity in Man by Crystalline Adenovirus Type 5 Capsid Antigens (1973) (19)
Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers (1979) (19)
Parenteral Inactivated Rhinovirus Vaccine: Minimal Protective Effect 1 (1972) (19)
Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illness (1994) (19)
Antibody to Rhinovirus in Human Sera. II. Heterotypic Responses∗ (1968) (19)
Antibody to Rhinovirus in Human Sera. I. Standardization of a Neutralization Test∗ (1968) (19)
Communications. Antigenic relationship between the equine and the Hong Kong human variant of influenza type A2 virus. (1969) (19)
A new antiviral agent for influenza--is there a clinical niche? (1997) (19)
Recovery of Applied Human Leukocyte Interferon from the Nasal Mucosa of Chimpanzees and Humans (1976) (18)
Picornavirus, the Most Common Respiratory Virus Causing Infection among Patients of All Ages Hospitalized with Acute Respiratory Illness (2011) (18)
Viruses and indoor air pollution. (1981) (18)
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants. (2008) (18)
Preparation and Properties of a Small-Particle Aerosol of Coxsackie A21 (1965) (17)
THE BASIS FOR IMMUNITY TO INFLUENZA IN MAN (1981) (17)
A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adults. (1981) (16)
Antigenicity of Licensed Whole Virion and Subvirion Influenza Vaccines in “High Risk” Persons (1976) (16)
Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses. (2007) (16)
Intranasal influenza vaccine: adding to the armamentarium for influenza control. (1999) (16)
Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus. (1975) (15)
Animal Influenza: Its Significance in Human Infection—Summary of Influenza Workshop VI (1975) (15)
Production of the Influenza Syndrome in Man with Equine Influenza Virus (1969) (15)
Atraumatic biopsy of nasal mucosa. (1969) (14)
Studies on the Inability of Rhinovirus to Survive and Replicate in The Intestinal Tract of Volunteers (1967) (14)
Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology. (1987) (14)
Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults. (1995) (13)
Growth and Gytopathic Effect of H Type Rhinoviruses in Monkey Kidney Tissue Culture (1966) (12)
Amantadine Therapy of Epidemic Influenza A2 (Hong Kong) (1970) (12)
HETEROGENEITY OF INFLUENZA VIRUSES ISOLATED FROM THE HOUSTON COMMUNITY DURING DEFINED EPIDEMIC PERIODS (1981) (12)
Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans. (1994) (11)
STUDIES IN VOLUNTEERS WITH RESPIRATORY VIRAL AGENTS: SMALL PARTICLE AEROSOL; HETEROTYPIC PROTECTION; VIRAL CHEMOTHERAPY; BOVINE REOVIRUS IN MAN. (1963) (10)
Effect of Influenza Anti-Neuraminidase Antibody on Virus Neutralization (1973) (10)
Assessment of experimental and natural viral aerosols (1966) (10)
Safety and pharmacokinetics of rimantadine small-particle aerosol (1990) (10)
The Virtues of Equality and Dissensus: MacIntyre in a Dialogue with Rancière and Mouffe (2020) (10)
Surveillance of influenza in Houston, Texas, USA: gradual transition from A/Victoria/75 (H3N2) to A/Texas/77 (H3N2) predominance and antigenic characterization of "intermediate" strains. (1983) (9)
Factors influencing response of volunteers to inoculation with Coxsackie virus A type 21. (1969) (9)
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine. (2011) (9)
Measures for Control of Influenza (2012) (9)
Effect of lack of gravity on airborne infection during space flight. (1970) (8)
Comparison ofDifferent Tissue Cultures forIsolation and Quantitation ofInfluenza andParainfluenza Viruses (1979) (8)
Characterization of the Infectious Unit for Man of Two Respiratory Viruses 1 (1972) (8)
Attenuation of Rhinovirus Type 15 for Humans (1969) (8)
Live attenuated intranasal influenza vaccine. (2002) (8)
Seasonal gastroenteritis and malabsorption at an American military base in the Philippines. 3. Microbiologic investigations and volunteer experiments. (1972) (7)
Antigenicity of alum and aqueous adenovirus hexon antigen vaccines in man. (1971) (7)
Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine. (1971) (7)
Cold doesn't affect the "common cold" in study of rhinovirus infections. (1967) (7)
RESPONSE OF VOLUNTEERS TO INOCULATION WITH HEMAGGLUTININ-POSITIVE AND HEMAGGLUTININ-NEGATIVE VARIANTS OF COXSACKIE A21 VIRUS. (1965) (7)
Are Fair Value Options Created Equal? A Study of SFAS 159 and Earnings Volatility (2014) (6)
Immunogenicity and protection in mice given inactivated influenza vaccine, MPL, QS-21 or QS-7 (2001) (6)
Ribavirin aerosol treatment of influenza B virus infection. (1983) (6)
Managing influenza in older patients. (1983) (6)
An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers. (1977) (6)
An Option for Lemons? The Fair Value Option for Liabilities During the Financial Crisis (2014) (6)
Economy Suspended: The Possibilities of a Badiouian Business Ethics (2013) (6)
Inactivated influenza vaccines (2002) (5)
Variant-Specific Antihemagglutinin Serum Response to Type A Influenza Natural Infection and Inactivated Vaccines in Adults 1 (1979) (5)
Determination of immunoglobulin A concentrations in human nasal secretions with a serum immunoglobulin A standard (1978) (5)
Attenuation of Rhinovirus Type 15: Relation of Illness to Plaque Size (1974) (5)
Anti-genie relationship between the equine and the Hong Kong human variant of influenza type A2 virus. (1969) (4)
The Shampoo Clue: Two Cases of Infection of a Ventriculoatrial Shunt (2000) (4)
Lessons Learned from Clinical Trials in 1976 and 1977 of Vaccines for the Newly Emerged Swine and Russian Influenza A/H1N1 Viruses (2011) (3)
23 – Oral Immunization with Influenza Virus Vaccines (1996) (3)
Fundamentals of submarine concept design. Discussion (1992) (3)
Aerosol inoculator for exposure of human volunteers. (1971) (3)
Genital herpes: an epidemic disease. (1983) (3)
Reverse Stock Splits in the Biotechnology Industry: An Effectuation Approach (2015) (3)
Challenge studies. (2003) (3)
Comparison ofRapidDiagnostic Techniques forRespiratory Syncytial andInfluenza A VirusRespiratory Infections inYoungChildren (1993) (2)
The fair value option for liabilities and stock returns during the financial crisis (2016) (2)
Correction: Integrative genomic analysis of the human immune response to influenza vaccination (2016) (2)
"interactive" version of data associated with the eLife paper "Integrative genomic analysis of the human immune response to influenza vaccination" (2013) (2)
Has oseltamivir been shown to be effective for treatment of H5N1 influenza? (2010) (2)
Portfolio Choice with Complementary Housing (2004) (2)
Author response: Integrative genomic analysis of the human immune response to influenza vaccination (2012) (2)
[Role of Mycoplasma pneumoniae in the etiology of acute respiratory infections in Ribeirao Preto, Sao Paulo, Brazil]. (1991) (1)
Data: an ethical overview (2017) (1)
Use of amantadine in the therapy and prophylaxis of A2 influenza. (1969) (1)
Pandemic influenza and the avian influenza A (H5N1) threat (1998) (1)
Lack of effect of influenza virus infection on induction and expression of delayed hypersensitivity. (1981) (1)
Research initiatives in studies of antiviral resistance and consensus points and recommendations. (1995) (1)
Financing development stage biotechnology companies: RMs vs. IPOs. (2011) (1)
Rimantadine (RIMA) in nasal secretions impairs accurate virus quantitation in humans undergoing antiviral treatment (1991) (1)
Private Investment and Public Equity Returns (2011) (1)
Appendix C.— Summary of Medical Literature Review of Effectiveness of Inactivated Influenza Virus Vaccines* (1979) (1)
IMM1UNITY TO INFLUENZA INMAN (1983) (0)
Living in regimes of data power: critical data studies and the paradigm of ethics (2017) (0)
Influenza--promising new developments. (1970) (0)
Studies in Volunteers with Respiratory Viral Agents1 (2015) (0)
Persistence of Antibody to Envelope Antigens of Heq2Neq2 Virus in Ponies after Infection and Vaccination (1974) (0)
Book dialog: a preface (2017) (0)
A Payback Approach to Generational Inequity (2016) (0)
Influenza--promising new developments. (1970) (0)
Panel discussion: session v. (1981) (0)
Direct ultracentrifugation and electron microscopy for rapid detection of viral infections (1986) (0)
Financing Development Stage Biotechnology Companies: Reverse Mergers vs. IPOs (2011) (0)
COMMUNICATIONS (1969) (0)
Influenza: Advances in Knowledge of Impact and Approaches to Control (2000) (0)
Education Reform and Cross-Sectoral Financing: A Practice-Based Approach (2012) (0)
Retraction for Woo et al., “False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid Enzyme-Linked Immunosorbent Assay Due to HCoV-OC43 and HCoV-229E Rectified by Western Blotting with Recombinant SARS-CoV Spike Polypeptide” (2022) (0)
Influenza B in hospitalized immunocompromised adults. (1997) (0)
Aerosol Inoculator for Exposure of Human Volunteers (1971) (0)
Influenza immunization. (1976) (0)
Occurrences of the Guillain–Barré Syndrome (GBS) After Vaccinations with the 1976 Swine A/H1N1 Vaccine, and Evolution of the Concern for an Influenza Vaccine-GBS Association (2011) (0)
Lymphocyte Cytotoxicity to Influenza Virus-Infected Cells (1977) (0)
Human DPP4 Transgenic Mice as Surrogate Models for MERS (2016) (0)
[Combined action of remantadine (amantadine) and ribavirin on experimental influenza]. (1981) (0)
EVALUATION OF A NEW ANALEPTIC: ETHAMIVAN (EMIVAN). (1964) (0)
Temperature-Sensitive Mutants of Influenza A Virus: Evaluation of the A/Victoria/75-ts-lA2 (2003) (0)
[Sero-epidemiologic observations on influenza virus infections in the state of Nuevo León 1978-1979]. (1982) (0)
Author's Comments on the Discussion (1966) (0)
AIDS Vaccine Development—1988 (1989) (0)
Alterations of thymus and lungs of influenza virus infected mice. Abstr. (1976) (0)
93 A trial of increasing dose of baculovirus-expressed trivalent influenza HA vaccine: Prospective, randomized, double-blind study in adult patients with B-cell non-Hodgkin's lymphoma (NHL) (2006) (0)
Missed Distress Signals: Evidence from the Fair Value Option for Liabilities (2012) (0)
Effect of methylprednisolone on antigen stimulated antibody formation in man (1974) (0)
Respiratory Viruses (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert B. Couch?

Robert B. Couch is affiliated with the following schools: